__timestamp | Corcept Therapeutics Incorporated | Sanofi |
---|---|---|
Wednesday, January 1, 2014 | 18372000 | 4667000000 |
Thursday, January 1, 2015 | 15419000 | 5082000000 |
Friday, January 1, 2016 | 23844000 | 5232000000 |
Sunday, January 1, 2017 | 40376000 | 5567000000 |
Monday, January 1, 2018 | 75247000 | 6350000000 |
Tuesday, January 1, 2019 | 89017000 | 6018000000 |
Wednesday, January 1, 2020 | 114764000 | 5529000000 |
Friday, January 1, 2021 | 113864000 | 5692000000 |
Saturday, January 1, 2022 | 130991000 | 6706000000 |
Sunday, January 1, 2023 | 184353000 | 6728000000 |
Monday, January 1, 2024 | 7394000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical landscape, research and development (R&D) budgets are pivotal in driving innovation. This analysis compares the R&D expenditures of two industry players: Sanofi, a global healthcare leader, and Corcept Therapeutics, a niche biopharmaceutical company. From 2014 to 2023, Sanofi consistently invested significantly more in R&D, with expenditures peaking at approximately $6.7 billion in 2023. In contrast, Corcept Therapeutics, while smaller in scale, demonstrated a remarkable growth trajectory, increasing its R&D spending by nearly tenfold over the same period, from $18 million in 2014 to $184 million in 2023. This stark contrast highlights the differing scales and strategies of these companies. Sanofi's robust R&D budget underscores its commitment to maintaining a competitive edge, while Corcept's rapid growth reflects its strategic focus on innovation within its specialized field.
R&D Insights: How Sanofi and Regeneron Pharmaceuticals, Inc. Allocate Funds
Comparing Innovation Spending: Sanofi and CymaBay Therapeutics, Inc.
R&D Insights: How Sanofi and Geron Corporation Allocate Funds
Research and Development Investment: Biogen Inc. vs Corcept Therapeutics Incorporated
Research and Development Investment: United Therapeutics Corporation vs Corcept Therapeutics Incorporated
Research and Development Investment: Viatris Inc. vs Corcept Therapeutics Incorporated
Exelixis, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and Corcept Therapeutics Incorporated
R&D Insights: How Pharming Group N.V. and Corcept Therapeutics Incorporated Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Grifols, S.A. and Corcept Therapeutics Incorporated
R&D Insights: How Corcept Therapeutics Incorporated and ImmunityBio, Inc. Allocate Funds
R&D Insights: How Corcept Therapeutics Incorporated and Supernus Pharmaceuticals, Inc. Allocate Funds